Otonomy, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The firm&#x27;s portfolio includes therapeutics for diseases and disorders of the ear such as otitis media, acute otitis externa, balance disorders, M&#xE9;ni&#xE8;re&#x27;s disease, tinnitus, cisplatin-induced hearing loss, and sensorineural hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan in April 2008 and is headquartered in San Diego, CA.
